Novo Nordisk Stock Crashes 22% After Disappoitning Obesity Drug Data. Eli Lilly Shares Soar.
Novo Nordisk stock fell sharply early Friday after the pharmaceutical giant, known for its blockbuster drugs Ozempic and ...
The Local2h
Danish krone weakened by Novo Nordisk share price crash
Denmark’s usually-stable currency was left weakened on Friday after the news that pharmaceutical giant Novo Nordisk, a major ...
Novo Nordisk’s Hiring Binge Leaves Danish Firms Starved of Labor
The maker of weight-loss and diabetes drugs has supercharged the Danish economy — but other businesses complain that’s left ...
Weight-loss Drugmaker Novo Nordisk's Shares Fall On Disappointing Study
Shares in Danish pharmaceutical giant Novo Nordisk, maker of diabetes and weight-loss treatments Ozempic and Wegovy, plunged on Friday after it announced disappointing results of a new drug study.
Novo Nordisk: Why The Market Sell-Off On CagriSema Data May Be Justified
Novo Nordisk's CagriSema Phase 3 data showed 22.7% weight loss, missing the company's own 25% target, causing a 20% drop in ...
Investing1h
Danish krone weakens following Novo Nordisk's clinical trial setback
Investing.com -- The Danish krone experienced a dip following disappointing clinical trial results from Denmark's pharmaceutical giant, Novo Nordisk (NYSE: NVO) A/S. The results have raised concerns ...
Pharmabiz15h
Novo Nordisk Foundation grants €134.1 mn to set up Biotechnology Research Institute for Green Transition in Denmark
Copenhagen, Denmark Friday, December 20, 2024, 10:00 Hrs [IST] ...
Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight in the REDEFINE 1 trial
Novo Nordisk today announced headline results from REDEFINE 1, a phase 3 trial in the global REDEFINE programme. REDEFINE 1 ...